Home Compare BIIB vs TMO
Stock Comparison · Structural lead, mixed market

Biogen vs Thermo Fisher Scientific: Which Stock Looks Stronger in 2026?

Thermo Fisher Scientific holds the cleaner structural position, with the lead spread across stability and profitability. Biogen still has the edge on valuation, which keeps the comparison from looking entirely one-sided. In the market, Biogen carries the stronger setup — intact trend against Thermo Fisher Scientific's broken trend. That leaves a split case: the structural lead stays with Thermo Fisher Scientific, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The lead is spread across stability and profitability, rather than sitting in one isolated gap. Thermo Fisher Scientific Inc. leads by 28 points on the overall comparison score.

Trajectory Similarity
0.70
Similar
Peer-set rank: #5
within Biogen Inc.'s functional peer set

This pair is matched through long-term financial trajectory similarity within the selected peer universe.

The pair sits on a clearly comparable long-term path, though it is not a near-twin match.

The clearest structural overlap shows up in revenue growth trajectory and investment intensity.

Similarity drivers
revenue growth trajectoryinvestment intensity
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
BIIB
Biogen Inc.
26
Peer-Score
Signal qualityHigh
vs
TMO
Thermo Fisher Scientific Inc.
54
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: BIIB vs TMO Profitability 0 50 Stability 10 62 Valuation 80 65 Growth 0 35 BIIB TMO
Gap Ranking
#1 Stability +52
#2 Profitability +50
#3 Growth +35
#4 Valuation +15
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for BIIB and TMO Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer BIIBTMO Relative valuation Structural strength

Thermo Fisher Scientific Inc. is cheaper, but Biogen Inc. is still stronger.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Stability
Thermo Fisher Scientific Inc. sits in the stronger part of the group on stability, while Biogen Inc. is closer to mid-pack.
Profitability
Thermo Fisher Scientific Inc. sits in the stronger part of the group on profitability, while Biogen Inc. is closer to mid-pack.
Stability — Dominant Gap
BIIB
10
TMO
62
Gap+52in favour of TMO

The stability gap is very wide, with the stronger side looking materially steadier through time.

What keeps the gap from being one-sided

Absolute pricing still looks more supportive for Biogen, with a forward P/E that is 6.3 turns lower there.

What this means for the comparison

The lead is built on both stability and profitability — though valuation still provides a counterweight.

Explore full peer positioning in AssetNext

Break down the BIIB vs TMO comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar stability-and-profitability comparisons

Explore how BIIB and TMO each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.